ロード中...
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state
13-cis-retinoic acid (RA) is typically used in post-remission maintenance therapy in patients with neuroblastoma. However, side effects and recurrence are often observed. We investigated the use of miRNAs as a strategy to replace RA as promoters of differentiation. miR-124 was identified as the top...
保存先:
| 出版年: | Mol Cancer Res |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6942226/ https://ncbi.nlm.nih.gov/pubmed/31624087 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-19-0187 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|